title: Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells.
abstract: BACKGROUND
  Rabies virus is the main etiologic agent of the widespread neurological disease rabies. Recently, the China rabies virus vaccine strain CTN-1 adapted to chicken embryo cells, which has been designated as CTNCEC25, was obtained and demonstrated to have high immunogenicity. However, the full genome sequence of CTNCEC25 and its phylogenetic relationship with other rabies virus street and vaccine strains have not been characterized.
  
  
  RESULTS
  The complete genome of CTNCEC25 was sequenced and analyzed. The length of CTNCEC25 genome is 11,924 nucleotides (nt), comprising a 3' leader sequence of 59 nt, nucleoprotein (N) gene of 1,425 nt, phosphoprotein (P) gene of 989 nt, matrix protein (M) gene of 803 nt, glycoprotein (G) gene of 2,067 nt, RNA-dependent RNA polymerase gene (L) of 6,474 nt and a 5' trailer region of 71 nt. A comparison of the entire genomes of CTN-1 and CTNCEC25 identified 16 nt substitutions and 1 deletion, resulting in 8 amino acid (aa) changes in the five structural proteins with one in L (aa 1602), two in M (aa 99 and 191) and six in mature G (aa 147, 333, 389, 421 and 485). The percentage homology of the CTNCEC25 genomic sequence with other fully sequenced rabies virus strains ranged from 81.4% to 99.9%. Phylogenetic analysis indicated that CTNCEC25 was more closely related with those recently isolated China street strains than other vaccine strains. Virus growth analysis showed that CTNCEC25 achieved high rate of propagation in cultured cells.
  
  
  CONCLUSIONS
  In this study, the complete genome of CTNCEC25 was sequenced and characterized. Our results showed that CTNCEC25 was more closely related to wild street strains circulating in China than other vaccine strains. Sequence analysis showed that the G protein ectodomain amino acid sequence identity between CTNCEC25 and other rabies virus strains was at least 90% identical. Furthermore, CTNCEC25 achieved high virus titers in cultured cells. Given that CTNCEC25 has high immunogenicity and induced strong protective immune response in animals, these results collectively demonstrated that CTNCEC25 is an ideal vaccine strain candidate for producing human vaccine with high quality and safety in China.
authors.forename: Shimao
authors.initials: S
authors.lastname: Zhu
authors.forename: Chunhua
authors.initials: C
authors.lastname: Wang
authors.forename: Pei
authors.initials: P
authors.lastname: Zhang
authors.forename: Hui
authors.initials: H
authors.lastname: Li
authors.forename: Shan
authors.initials: S
authors.lastname: Luo
authors.affiliation: Shenzhen Weiguang Biological Products Co,, Ltd, Shenzhen 518107, Guangdong province, China. gcpzxy0402@aliyun.com.
authors.forename: Caiping
authors.initials: C
authors.lastname: Guo
mesh_terms: D000222:Adaptation, Physiological; D000818:Animals; D001483:Base Sequence; D002642:Chick Embryo / Q000821:virology*; D002645:Chickens; D002681:China; D016679:Genome, Viral; D008969:Molecular Sequence Data; D010802:Phylogeny; D011818:Rabies / Q000821:virology; D011819:Rabies Vaccines / Q000235:genetics*; D011820:Rabies virus / Q000145:classification / Q000235:genetics* / Q000254:growth & development / Q000502:physiology; D014764:Viral Proteins; D014776:Virus Cultivation
chemical_list: D011819:Rabies Vaccines; D014764:Viral Proteins